GSMA
18.9.2018 12:43:07 CEST | Business Wire | Press release
Europe’s mobile ecosystem is forecast to account for more than 4 per cent of the region’s GDP by 2022, but the right regulatory action must be taken to position Europe as a global 5G leader and establish a genuine EU Digital Single Market, according to a new report published by the GSMA today. The latest regional edition of the GSMA’s flagship Mobile Economy series was released today at the GSMA Mobile 360 – Europe conference, where senior representatives from the mobile industry and regulatory bodies are convening to debate the future of telecoms in Europe.
“5G networks in Europe are expected to provide coverage to almost three-quarters of the region’s population by 2025 and Europe is set to become the world’s third-largest 5G market behind Asia Pacific and North America by this point,” commented Mats Granryd, Director General of the GSMA. “However, success in the 5G era will rest on the ability of governments to implement forward-looking regulatory frameworks that encourage sustainable investment, drive innovation and protect consumers.”
Mobile a Driver of Economic Growth in Europe
In 2017, mobile technologies and services generated 3.3 per cent of GDP1 in Europe, a contribution that amounted to EUR550 billion of economic value added. This contribution is expected to increase to EUR720 billion (4.1 per cent of GDP) by 2022. Europe’s mobile ecosystem also supported 2.5 million jobs in the region in 2017 and made a public funding contribution of EUR100 billion – mainly in the form of general taxation, including VAT, corporate taxes and employment taxes.
Reforms to Drive Digital Evolution
For Europe to realise the full potential of 5G, it needs to create a more supportive policy environment that positions it as a preferred location for investment. Regulation should seek to:
- Encourage a strong pro-investment environment that will allow the mobile industry to make investments that will ultimately benefit consumers;
- Support a policy of ‘same service, same rules’ that would lead to more competition, innovation and higher consumer welfare;
- Provide timely access to harmonised spectrum in the right frequencies, at the right time, and under the right long-term conditions for operators to invest in future networks and services; and
- Enable European operators to harness the full potential of data to innovate and compete globally while protecting the privacy and confidentiality of consumers
Europe Prepares to Move to 5G
Europe is the most highly penetrated regional mobile market in the world. According to today’s report, there were 465 million unique mobile subscribers2 in Europe at the end of 2017, representing 85 per cent of the population. This is forecast to grow to 481 million – 88 per cent of the population – by 2025.
Although there is still headroom for 4G growth in many markets, the first 5G launches by European mobile operators are anticipated by the end of the decade. By 2025, it is forecast that 5G will account for around 200 million connections, corresponding to a 29 per cent share of total connections in Europe.3
“Momentum is now building in Europe as we enter the 5G era, as mobile operators conduct trials and prepare to ramp up 5G investments over the coming years,” added Granryd. “Meanwhile, in light of ongoing financial and competitive pressures, Europe’s operators are looking beyond their core telco business in order to explore and unlock new revenue streams in both consumer and enterprise markets across a range of verticals.”
The new report ‘The Mobile Economy: Europe 2018’ is authored by GSMA Intelligence, the research arm of the GSMA. To access the full report and related infographics, please visit: www.gsma.com/mobileeconomy/europe/
-ENDS-
About the GSMA
The GSMA represents the interests of mobile operators worldwide, uniting more than 750 operators with over 350 companies in the broader mobile ecosystem, including handset and device makers, software companies, equipment providers and internet companies, as well as organisations in adjacent industry sectors. The GSMA also produces industry-leading events such as Mobile World Congress, Mobile World Congress Shanghai, Mobile World Congress Americas and the Mobile 360 Series of conferences.
For more information, please visit the GSMA corporate website at www.gsma.com . Follow the GSMA on Twitter: @GSMA .
1 GDP contribution includes direct mobile ecosystem contribution (0.9%); indirect contribution (0.5%); and productivity improvements (1.9%)
2 A unique mobile subscriber represents an individual that can account for multiple SIM connections
3 Excluding licenced cellular IoT connections
View source version on businesswire.com: https://www.businesswire.com/news/home/20180918005468/en/
Contact:
For the GSMA Beau Bass +44 79 7662 4962 beau.bass@webershandwick.com or Olivier Lechien +32 479 99 01 63 olechien@gsma.com or GSMA Press Office pressoffice@gsma.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 16:00:00 CEST | Press release
As pharma manufacturers prioritize US supply chain resilience, highlights include high-speed isolator filling lines for prefilled syringes, cartridges and vials, and drug-device combination assembly and packaging. PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpi
Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 15:53:00 CEST | Press release
Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor
Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 15:00:00 CEST | Press release
Phase 1 dose-escalation trial represents the first clinical trial of a product developed using the AraLinQ™ ADC technology and marks Taiho’s expansion into the clinical development of ADCs for oncology Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug co
Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 15:00:00 CEST | Press release
Premier global event to highlight how organizations are bringing data to life to power everything from AI to BI Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world.
Axinn Appoints Rachael Philbin as Chief Innovation Officer27.4.2026 15:00:00 CEST | Press release
Appointment Reflects Firm's Vision for the Future of Legal Practice Axinn, Veltrop & Harkrider LLP today announced the appointment of Rachael Philbin as Chief Innovation Officer, reinforcing the firm’s continued investment in advanced solutions and technology for legal services delivery. Philbin joins from Proskauer Rose LLP, where she served as Innovation & Transformation Officer. Based in Axinn's New York office, she will lead the firm’s AI and legal technology initiatives as well as knowledge management efforts, accelerating adoption and integration across its antitrust, intellectual property, and litigation practices. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427277725/en/ Rachael Philbin joins Axinn, Veltrop & Harkrider LLP as Chief Innovation Officer. “As Axinn continues to grow, we are making deliberate investments in the capabilities that enable our lawyers to deliver service and results at the highest level
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
